183 related articles for article (PubMed ID: 32923382)
1. Blood Biomarkers of Glioma in Response Assessment Including Pseudoprogression and Other Treatment Effects: A Systematic Review.
Raza IJ; Tingate CA; Gkolia P; Romero L; Tee JW; Hunn MK
Front Oncol; 2020; 10():1191. PubMed ID: 32923382
[TBL] [Abstract][Full Text] [Related]
2. Blood-Based Biomarkers in High Grade Gliomas: a Systematic Review.
Pierscianek D; Ahmadipour Y; Oppong MD; Rauschenbach L; Kebir S; Glas M; Sure U; Jabbarli R
Mol Neurobiol; 2019 Sep; 56(9):6071-6079. PubMed ID: 30719642
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.
Abbasi AW; Westerlaan HE; Holtman GA; Aden KM; van Laar PJ; van der Hoorn A
Clin Neuroradiol; 2018 Sep; 28(3):401-411. PubMed ID: 28466127
[TBL] [Abstract][Full Text] [Related]
4. Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.
Gheytanchi E; Madjd Z; Janani L; Rasti A; Ghods R; Atyabi F; Asadi-Lari MH; Babashah S
Syst Rev; 2017 Nov; 6(1):228. PubMed ID: 29149908
[TBL] [Abstract][Full Text] [Related]
5. Circulating glioma biomarkers.
Kros JM; Mustafa DM; Dekker LJ; Sillevis Smitt PA; Luider TM; Zheng PP
Neuro Oncol; 2015 Mar; 17(3):343-60. PubMed ID: 25253418
[TBL] [Abstract][Full Text] [Related]
6. Blood-Based Biomarkers for Glioma in the Context of Gliomagenesis: A Systematic Review.
Ali H; Harting R; de Vries R; Ali M; Wurdinger T; Best MG
Front Oncol; 2021; 11():665235. PubMed ID: 34150629
[TBL] [Abstract][Full Text] [Related]
7. Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti-Programmed Cell Death 1 Antibodies.
Lee JH; Long GV; Menzies AM; Lo S; Guminski A; Whitbourne K; Peranec M; Scolyer R; Kefford RF; Rizos H; Carlino MS
JAMA Oncol; 2018 May; 4(5):717-721. PubMed ID: 29423503
[TBL] [Abstract][Full Text] [Related]
8. Endometrial biomarkers for the non-invasive diagnosis of endometriosis.
Gupta D; Hull ML; Fraser I; Miller L; Bossuyt PM; Johnson N; Nisenblat V
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD012165. PubMed ID: 27094925
[TBL] [Abstract][Full Text] [Related]
9. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review.
Calanzani N; Druce PE; Snudden C; Milley KM; Boscott R; Behiyat D; Saji S; Martinez-Gutierrez J; Oberoi J; Funston G; Messenger M; Emery J; Walter FM
Adv Ther; 2021 Feb; 38(2):793-834. PubMed ID: 33306189
[TBL] [Abstract][Full Text] [Related]
10. Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis.
Delgado-López PD; Riñones-Mena E; Corrales-García EM
Clin Transl Oncol; 2018 Aug; 20(8):939-953. PubMed ID: 29218626
[TBL] [Abstract][Full Text] [Related]
11. Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review.
Vafaei S; Fattahi F; Ebrahimi M; Janani L; Shariftabrizi A; Madjd Z
Cancer Manag Res; 2019; 11():8669-8698. PubMed ID: 31576171
[TBL] [Abstract][Full Text] [Related]
12. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
[TBL] [Abstract][Full Text] [Related]
13. Circulating cancer stem cell markers in breast carcinomas: a systematic review protocol.
Mansoori M; Madjd Z; Janani L; Rasti A
Syst Rev; 2017 Dec; 6(1):262. PubMed ID: 29258583
[TBL] [Abstract][Full Text] [Related]
14. Blood-based biomarkers for malignant gliomas.
Holdhoff M; Yovino SG; Boadu O; Grossman SA
J Neurooncol; 2013 Jul; 113(3):345-352. PubMed ID: 23670054
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of fundus autofluorescence imaging for the diagnosis and monitoring of retinal conditions: a systematic review.
Frampton GK; Kalita N; Payne L; Colquitt J; Loveman E
Health Technol Assess; 2016 Apr; 20(31):1-108. PubMed ID: 27115052
[TBL] [Abstract][Full Text] [Related]
16. Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma.
Ceschin R; Kurland BF; Abberbock SR; Ellingson BM; Okada H; Jakacki RI; Pollack IF; Panigrahy A
AJNR Am J Neuroradiol; 2015 Nov; 36(11):2170-6. PubMed ID: 26338910
[TBL] [Abstract][Full Text] [Related]
17. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
